Position in RXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,378,537
-$4,243,041 QoQ
Shares Held
3,917,858
-35.4% QoQ
Ownership
0.732%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 344 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Derivatives in RXRX
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$592,852
PutShares
87,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. RXRX ranks #141 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in RXRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,378,537 | 3,917,858 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $18,621,578 | 6,065,661 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,003,896 | 2,201,442 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $6,156,704 | 1,261,620 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,723,962 | 1,131,218 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,913,114 | 1,495,863 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $592,852 | 87,700 | Put | Defined | 2025-02-11 | |
| 2024-12-31 | $13,960,804 | 2,065,208 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $577,943 | 87,700 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $10,146,649 | 1,539,704 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,029,125 | 1,070,550 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $8,943,289 | 897,020 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $11,751,196 | 1,191,805 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $5,085,512 | 664,773 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $4,313,513 | 577,445 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $3,569,295 | 535,127 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $4,494,945 | 583,002 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $3,809,821 | 358,066 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $1,595,984 | 196,067 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $1,499,368 | 209,409 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,117,028 | 123,586 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $429,526 | 18,667 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $401,974 | 11,013 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||